Company Information
Covance Inc Website Annual Report
210 Carnegie Center Phone: +1 609 452-4440
Princeton NEW JERSEY 08540-6233
Fax: +1 609 452-9375
Covance Inc.. The Group's principal activity is to provide a wide range of product development services, on a worldwide basis, primarily to the pharmaceutical, biotechnology and medical device industries. The Group also provides laboratory-testing services to the chemical, agrochemical and food industries. The operations of the Group are carried out through two segments. The Early Development services segment includes preclinical and Phase I clinical service capabilities. This involves evaluating a new compound for safety and early effectiveness as well as evaluating the absorption, distribution, metabolism and excretion of the compound in the human body. The Late-stage Development services segment includes central laboratory, clinical development, commercialization and other clinical support services.
-------
CVD is their ticker.
CoVance spells {Victory} for all CTUM shareholders